Epirus Biopharmaceuticals Inc Share Price Other OTC
Equities
US29428P1075
Biotechnology & Medical Research
Sales 2014 | 0 0.33 | Sales 2015 | 0.7 58.5 | Capitalization | 75.33M 6.29B |
---|---|---|---|---|---|
Net income 2014 | -41M -3.42B | Net income 2015 | -52M -4.34B | EV / Sales 2014 | 14,77,02,94,750 x |
Net cash position 2014 | 14.18M 1.18B | Net cash position 2015 | 16.68M 1.39B | EV / Sales 2015 | 8,36,58,631 x |
P/E ratio 2014 |
-0.83
x | P/E ratio 2015 |
-1.35
x | Employees | - |
Yield 2014 * |
-
| Yield 2015 |
-
| Free-Float | 100% |
1st Jan change | Capi. | |
---|---|---|
+31.12% | 49.46B | |
+1.11% | 42.58B | |
+49.00% | 42.49B | |
-5.26% | 29.09B | |
+12.73% | 26.61B | |
-23.76% | 18.64B | |
+7.24% | 13.16B | |
+31.35% | 12.55B | |
+23.77% | 12.1B |